Atalaya Capital Management (Atalaya), an alternative asset manager focused on private credit and special opportunities investments, has successfully exited its investment in The SAILS Group (SAILS), provider of residential care homes and other high touch treatment for behaviourally challenged clients, and Patterns Behavioral Services (Patterns), a provider of comprehensive services
Maven Capital Partners (Maven), has invested a further GBP500,000 in GENinCode, a genetic testing company specialising in the risk assessment and prediction of cardiovascular disease. This funding package comes as the company completes its IPO, raising an additional GBP17 million gross and listing on AIM with a market capitalisation of
SYNLAB is to acquire Laboratorio Médico Polanco and Laboratorio Clinicos de Puebla (LMP & LCR), a network of over 100 diagnostic service points in Mexico. By integrating LMP & LCR into the international SYNLAB laboratory network, SYNLAB will strengthen its strategic position in the region. SYNLAB will be ideally structured
T-Knife Therapeutics, a portfolio company of European investment management firm Andrea Partners, has completed a USD110 million Series B financing. The financing was led by Fidelity Management & Research Company, with participation from other new investors including LSP, Qatar Investment Authority (QIA), Casdin Capital, Sixty Degree Capital, and CaaS Capital,
Segulah Medical Acceleration AB (SMA) has invested in UK-based Signifier Medical Technologies’ USD35 million Series D convertible financing.
Ropes & Gray has advised WellSky Corporation – a portfolio company of TPG Capital and Leonard Green & Partners – on the sale of WellSky International to System C Healthcare, a provider of information technology implementation software and services to the health sector – and portfolio company of CVC Capital
The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in MDoutlook, a provider of precision intelligence solutions that help life sciences companies develop and commercialise therapeutics and diagnostics in oncology. This is an add-on to Riverside’s Clinical Education Alliance, LLC (CEA)
ARQIS has advised Liberta Partners on the sale of novelex AG to H&T Presspart, a division of Heitkamp & Thumann Group. The company, headquartered in Nidau, Switzerland, is a specialist in the design, development and manufacture of complex total plastic solutions for the pharmaceutical, diagnostics and medical technology industries.
Topas Therapeutics GmbH (Topas), a private biotechnology company developing immune tolerance-inducing drugs to treat and potentially cure a variety of autoimmune diseases, today announced that the Company has successfully extended its Series B round with an additional EUR18 million (~USD22 million) raised, bringing the total for this financing to EUR40
Vira Health, a digital health company focused on improving long-term health for women, has raised GBP1.5 million in seed funding from LocalGlobe, MMC Ventures, and angel investors including Megumi Ikeda, Managing Director, Hearst Ventures, Andrea Zitna of Elvie, former Spotify executive Sofia Bendz, founder of GoCardless Matt Robinson, and Simon
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
